Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis

Näytä muut versiot (1)

We have analysed data on exacerbation rates, Expanded Disability Status Scale (EDSS) scores, and lesion burdens using the results of two neutralizing antibody (NAB) assays (CPE and MxA) from the pivotal relapsing-remitting multiple sclerosis (MS) trial of interferon beta-1b (IFNB) with a longitudina...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Petkau, A, White, R, Ebers, G, Reder, A, Sibley, W, Lublin, F, Paty, D, Duquette, P, Girard, M, Despault, L, DuBois, R, Knobler, R, Kelley, L, Francis, G, Lapierre, Y, Antel, J, Freedman, M, Hum, S, Greenstein, J, Mishra, B, Muldoon, J, Whitaker, J, Evans, B, Layton, B, Laguna, J
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: 2004

Samankaltaisia teoksia